ONYX PHARMACEUTICALS INC 4
4 · ONYX PHARMACEUTICALS INC · Filed Dec 5, 2007
Insider Transaction Report
Form 4
KENNEY EDWARD F
EVP, Chief Business Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2007-12-03−3,000→ 25,000 totalExercise: $20.81Exp: 2015-08-31→ Common Stock (3,000 underlying) - Exercise/Conversion
Common Stock
2007-12-03$20.81/sh+3,000$62,430→ 30,000 total - Sale
Common Stock
2007-12-03$54.76/sh−3,000$164,280→ 27,000 total
Footnotes (2)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]The shares vest monthly from the date of grant at a rate of 1/48th per month over a period of 48 months.